Literature DB >> 2562547

The role of apraclonidine hydrochloride in laser therapy for glaucoma.

A L Robin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2562547      PMCID： PMC1298562     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN： 0065-9533


× No keyword cloud information.
  89 in total

1.  GLAUCOMA FOLLOWING CATARACT EXTRACTION ASSOCIATED WITH USE OF ALPHA-CHYMOTRYPSIN.

Authors:  R E KIRSCH
Journal:  Arch Ophthalmol       Date:  1964-11

2.  Prophylactic treatment of intraocular pressure elevations after neodymium: YAG laser posterior capsulotomies and extracapsular cataract extractions with levobunolol.

Authors:  D E Silverstone; G D Novack; E P Kelley; K S Chen
Journal:  Ophthalmology       Date:  1988-06       Impact factor: 12.079

3.  Aspirin prevents the disruption of the blood-aqueous barrier in the rabbit eye.

Authors:  A H Neufeld; L M Jampol; M L Sears
Journal:  Nature       Date:  1972-07-21       Impact factor: 49.962

4.  [Does Catapresan reduce the intraocular pressure independently from blood pressure?].

Authors:  W Leydhecker; E Hertlein
Journal:  Klin Monbl Augenheilkd       Date:  1971-11       Impact factor: 0.700

5.  [Effect of catapresan on the glaucomatous eye].

Authors:  G Jünemann; G Schmidt
Journal:  Klin Monbl Augenheilkd       Date:  1970-08       Impact factor: 0.700

6.  [Mode and principle of action of Catapresan in glaucoma therapy].

Authors:  G Jünemann; E Paust
Journal:  Klin Monbl Augenheilkd       Date:  1971-04       Impact factor: 0.700

7.  The effect of repeat argon laser trabeculoplasty.

Authors:  P A Jorizzo; J R Samples; E M Van Buskirk
Journal:  Am J Ophthalmol       Date:  1988-12-15       Impact factor: 5.258

8.  Aqueous flow is reduced by the alpha-adrenergic agonist, apraclonidine hydrochloride (ALO 2145).

Authors:  N Z Gharagozloo; S J Relf; R F Brubaker
Journal:  Ophthalmology       Date:  1988-09       Impact factor: 12.079

9.  Experimental glaucoma in the rhesus monkey.

Authors:  D Gaasterland; C Kupfer
Journal:  Invest Ophthalmol       Date:  1974-06

10.  Adjunctive glaucoma therapy. A comparison of apraclonidine to dipivefrin when added to timolol maleate.

Authors:  J C Morrison; A L Robin
Journal:  Ophthalmology       Date:  1989-01       Impact factor: 12.079
View more
  6 in total

1.  Topical apraclonidine hydrochloride in eyes with poorly controlled glaucoma. The Apraclonidine Maximum Tolerated Medical Therapy Study Group.

Authors:  A L Robin; R Ritch; D Shin; B Smythe; T Mundorf; R P Lehmann
Journal:  Trans Am Ophthalmol Soc       Date:  1995

Review 2.  New developments in the drug treatment of glaucoma.

Authors:  L M Hurvitz; P L Kaufman; A L Robin; R N Weinreb; K Crawford; B Shaw
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

3.  Efficacy of apraclonidine ophthalmic solution (Iopidine) in presumed silicon oil-induced glaucoma and primary open-angle glaucoma.

Authors:  E Gramer; S Busche; A Kampik; D Parsons
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-01       Impact factor: 3.117

Review 4.  Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty.

Authors:  Linda Zhang; Jennifer S Weizer; David C Musch
Journal:  Cochrane Database Syst Rev       Date:  2017-02-23

Review 5.  The impact of timolol maleate on the ocular tolerability of fixed-combination glaucoma therapies.

Authors:  Nathan M Radcliffe
Journal:  Clin Ophthalmol       Date:  2014-12-12

Review 6.  Where does selective laser trabeculoplasty stand now? A review.

Authors:  Myrjam De Keyser; Maya De Belder; Simon De Belder; Veva De Groot
Journal:  Eye Vis (Lond)       Date:  2016-04-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.